Literature DB >> 11511003

Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity.

J Walochnik1, A Obwaller, E M Haller-Schober, H Aspöck.   

Abstract

Several representatives of the genus Acanthamoeba are known as causative agents of Acanthamoeba keratitis and granulomatous amoebic encephalitis. These occur predominantly in the immunocompromised host, but it is still unclear what primes the amoebae for pathogenicity. The aim of this study was to assess possible immunological differences between a highly pathogenic and a nonpathogenic Acanthamoeba strain. A total of 20 sera, including two sera of Acanthamoeba keratitis patients, were tested for anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities using immunoblotting. All sera were positive for Acanthamoeba, revealing two predominant bands at 29 kDa and at 47 kDa, respectively. Interestingly, IgG and particularly IgA immunoreactivity enabled a clear discrimination between the pathogenic and nonpathogenic strains. Moreover, compared to the control sera, the two sera of Acanthamoeba keratitis patients showed rather weak immunoreactivities and they lacked the 29 kDa and the 47 kDa band in the IgA immunoblot against the pathogenic strain. The results of our study support the assumption that immunological predisposition might also be of importance in Acanthamoeba keratitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511003     DOI: 10.1007/s004360100412

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  12 in total

1.  Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis.

Authors:  M Garate; H Alizadeh; S Neelam; J Y Niederkorn; N Panjwani
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

2.  Effect of oxidative stress on vital indicators of Acanthamoeba castellanii (T4 genotype).

Authors:  Mousa Motavalli; Iraj Khodadadi; Mohammad Fallah; Amir Hossein Maghsood
Journal:  Parasitol Res       Date:  2018-07-09       Impact factor: 2.289

3.  Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles.

Authors:  J Walochnik; K Sommer; A Obwaller; E-M Haller-Schober; H Aspöck
Journal:  Parasitol Res       Date:  2004-01-13       Impact factor: 2.289

4.  Granulomatous amoebic encephalitis caused by Acanthamoeba amoebae of genotype T2 in a human immunodeficiency virus-negative patient.

Authors:  Julia Walochnik; Alexander Aichelburg; Ojan Assadian; Andrea Steuer; Govinda Visvesvara; Norbert Vetter; Horst Aspöck
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

Review 5.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 6.  Biology and pathogenesis of Acanthamoeba.

Authors:  Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Parasit Vectors       Date:  2012-01-10       Impact factor: 3.876

Review 7.  Twenty years of acanthamoeba diagnostics in Austria.

Authors:  Julia Walochnik; Ute Scheikl; Eva-Maria Haller-Schober
Journal:  J Eukaryot Microbiol       Date:  2014-09-25       Impact factor: 3.346

Review 8.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000

9.  Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability.

Authors:  Lidia Chomicz; David Bruce Conn; Marcin Padzik; Jacek P Szaflik; Julia Walochnik; Paweł J Zawadzki; Witold Pawłowski; Monika Dybicz
Journal:  Biomed Res Int       Date:  2015-11-23       Impact factor: 3.411

10.  Lethal outcome of granulomatous acanthamoebic encephalitis in a man who was human immunodeficiency virus-positive: a case report.

Authors:  Stefanie Geith; Julia Walochnik; Franz Prantl; Stefan Sack; Florian Eyer
Journal:  J Med Case Rep       Date:  2018-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.